Preparing your results

Our searching services are busy right now. Your search will reload in five seconds.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

The SCF-Fbw7 ubiquitin ligase degrades MED13 and MED13L and regulates CDK8 module association with Mediator.

Genes & development | Jan 15, 2013

http://www.ncbi.nlm.nih.gov/pubmed/23322298

The Mediator complex is an essential transcription regulator that bridges transcription factors with RNA polymerase II. This interaction is controlled by dynamic interactions between Mediator and the CDK8 module, but the mechanisms governing CDK8 module-Mediator association remain poorly understood. We show that Fbw7, a tumor suppressor and ubiquitin ligase, binds to CDK8-Mediator and targets MED13/13L for degradation. MED13/13L physically link the CDK8 module to Mediator, and Fbw7 loss increases CDK8 module-Mediator association. Our work reveals a novel mechanism regulating CDK8 module-Mediator association and suggests an expanded role for Fbw7 in transcriptional control and an unanticipated relationship with the CDK8 oncogene.

Pubmed ID: 23322298 RIS Download

Mesh terms: Cell Line, Tumor | Cyclin-Dependent Kinase 8 | Gene Expression Regulation, Neoplastic | HEK293 Cells | HeLa Cells | Humans | Mediator Complex | Protein Binding | Proteolysis | SKP Cullin F-Box Protein Ligases | Ubiquitination

Research resources used in this publication

None found

Research tools detected in this publication

None found

Data used in this publication

None found

Associated grants

  • Agency: NCI NIH HHS, Id: CA084069
  • Agency: NCI NIH HHS, Id: CA102742
  • Agency: NCI NIH HHS, Id: CA127364
  • Agency: NCI NIH HHS, Id: R01 CA084069
  • Agency: NCI NIH HHS, Id: T32 CA080416
  • Agency: NCI NIH HHS, Id: T32 CA080416

BioGRID (Data, Interactions)

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.